BTX : Summary for BioTime, Inc. Common Stock - Yahoo Finance

U.S. Markets closed

BioTime, Inc. (BTX)


NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
3.30+0.11 (+3.45%)
At close: 4:01 PM EST

3.30 0.00 (0.00%)
After hours: 5:20 PM EST

People also watch:
ASTNNVCISCOCURCYTX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close3.19
Open3.26
Bid3.28 x 400
Ask3.30 x 600
Day's Range3.12 - 3.32
52 Week Range2.02 - 4.51
Volume278,138
Avg. Volume313,590
Market Cap341.19M
Beta1.94
PE Ratio (TTM)12.55
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube6 days ago

    ETFs with exposure to BioTime, Inc. : November 30, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to BioTime, Inc. Here are 5 ETFs with the largest exposure to BTX-US. Comparing the performance and risk of BioTime, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • BioTime, Inc. breached its 50 day moving average in a Bearish Manner : BTX-US : November 29, 2016
    Capital Cube7 days ago

    BioTime, Inc. breached its 50 day moving average in a Bearish Manner : BTX-US : November 29, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for BioTime, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)

  • Benzinga14 days ago

    BioTime CEO Explains What Could Happen To Stem Cell Research And The Company Under A New Guard In Washington

    BioTime, Inc. (NYSE: BTX ) is a clinical-stage biotechnology company working on regenerative medicine and pluripotent stem cell technologies. Dr. Michael D. West, the original founder of Geron Corporation ...